What causes lipoatrophy in HIV infection?

Updated: Sep 07, 2018
  • Author: Jason F Okulicz, MD, FACP, FIDSA; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print
Answer

Answer

The comorbidities listed below may require management.

Abnormalities of body fat distribution

These are a recognized complication of ART. Lipohypertrophy has been variably associated with PIs and with nucleoside reverse transcriptase inhibitors (NRTIs). Lipoatrophy is most commonly associated with NRTIs, specifically stavudine, didanosine, and zidovudine. Once body shape changes occur, they cannot be reliably reversed, and switching to an NRTI-sparing regimen can slowly improve limb fat in patients with lipoatrophy but does not help patients with lipohypertrophy.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!